Banyan BioInnovations Launches as an Investment Firm to Support Clinical-Stage Drug Assets, Secures More Than $100M in Initial Commitments from Life Science Investors

Leverages Locust Walk's global asset sourcing capabilities across the US, Asia, and Europe to co-found NewCos with drug originators Provides comprehensive support to accelerate and de-risk drug development through value-creating clinical and regulatory milestones BOSTON, May 5, 2026...